The magnificent 7? Review finds that different “talking therapies” offer similar benefits to people with depression

Talking

Scientific studies comparing treatments for depression and depressive disorders keep the mental elves very busy. Most months we are asked to blog on about 3 newly published reviews on this hot topic. The interest in research on the treatment of depression comes as no surprise, when one considers that depressive disorders affect a staggering one-fifth of people in high earning countries at some stage in their lives (e.g. Jacobi et al).

The BBC recently reported on a study carried out by SSentif  –  a data analysis company – which showed that nearly 5 million people were registered sufferers of depression in England in 2011 and that this figure represented an increase of almost 11% in 3 years (SSentif);   the WHO predicts that depression will become the number 2 cause of ill health in the next 20 years (e.g. Mathers & Loncar).

Most sufferers of depression are offered medication (mainly antidepressants) and/or psychotherapy (“talking therapy”) and both have been repeatedly shown to help alleviate depressive symptoms.

Talking therapy is a catch all term covering a whole range of different schools (psychodynamic, humanistic, cognitive and behavioural) and within these schools scores of different models. It is accepted that talking therapies benefit depressed people; it is less clear which (if any) is the preferred approach.

A recently published meta-analysis (Barth et al) reviewed the scientific evidence on a variety of psychotherapeutic approaches in an attempt to examine the relative efficacy of seven different psychotherapeutic interventions in adults with depression.

A staircase of books

The review included 198 studies of the effects of talking treatments.

What did they study?

Researchers from Switzerland, the UK and The Netherlands conducted the study. It reviewed 14,237 references (using PubMed, PsycINFO, Embase, Cochrane, WHO Afro Library) and included 198 randomised trials, which met all of the studies criteria – essentially studies that assessed the efficacy of psychotherapies against a control cohort and excluded any study which included any additional depression specific medication(s).

They identified 5 descriptive categories across the 198 studies:

  • Patient population (type of depression, with 47% being characterised as “regular depression”)
  • Psychotherapeutic intervention (Interpersonal therapy – IPT; Behavioural activation – BA; Cognitive behavioural therapy – CBT; Problem solving therapy – PST; Social skills training – SST; Supportive counselling – 70% of the included studies involved CBT)
  • Control condition (placebo, usual care or wait list)
  • Intervention format and setting (individual/face-to-face or “other”)
  • Country (58% of the studies included being conducted in USA)

The study gave clear definitions and descriptions for the seven intervention strategies, which help the reader understand the differences and similarities of the talking therapies included.

What did they find?

Each of the seven forms of talking therapy was superior to a waitlist control condition (moderate to large effects; range d= -0.62 to d= -0.92). The authors also identified that IPT appeared to be more effective than supportive therapy. More in-depth comparisons (using stepwise restriction analyses by sample size) demonstrated robust effects for CBT, IPT and PST (all d>0.46).

What did they conclude?

Based on 198 publications testing the benefits of talking therapies, which included over 15,000 adults with depression, the authors concluded:

Overall our results are consistent with the notion that different psychotherapeutic interventions for depression have comparable benefits.

Magnifying glass

The ability of the review to draw definitive overall conclusions was limited by the clinical differences between the studies.

Limitations

The authors identified a number of limitations of their study, including the fact that they included both clinician ratings and self-reporting ratings, which are known to differ (clinicians tend to find greater levels of recovery when compared to patient rated studies). The study was also limited to studies carried out in Western countries. It was also impossible to assess long-term effects of the treatments studied.

In addition to the limitations the authors emphasised, this study also seems to somewhat limited by:

  • the inclusion of such a diverse range of populations (regular depression, geriatric depression, students populations, women with post-natal depression, general medical patients with depression)
  • the inclusion of not only individual face-to-face approaches, but also of ill-defined “other” (50% of the studies) and “mixed” (1%) formats and settings.

Due to this heterogeneity between the studies, the review cannot tell us definitively which treatment is better, or whether there is an equivalence between them.

And finally…

This study adds weight to the theory that people with depression gain significant benefits from talking therapies and seems to be suggesting that CBT, IPT and PST can be effective in treating this common mental health problem.

Links

Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, et al. (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med 34: 597–611. doi: http://dx.doi.org/10.1017/s0033291703001399.  [PubMed abstract]

Depression up ‘by half a millionBBC Health News Online, 17 October 2012.

SSENTIF News. The great depression: is the UK facing a mental health crisis? Read the Press Release.

Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442 10.1371/journal.pmed.0030442. doi: http://dx.doi.org/10.1371/journal.pmed.0030442.

Barth J, Munder T, Gerger H, Nüesch E, Trelle S, et al. (2013) Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis. PLoS Med 10(5): e1001454. doi:10.1371/journal.pmed.100145.

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Profile photo of Mark Smith

Mark Smith

Mark is a psychotherapist who works as an IAPT High Intensity clinician for a leading service provider in the East Midlands. He has a great deal of experience working with patients with common mental health issues and is particularly interested in depression, generalised anxiety, addictions, Personality Disorders and the use of outcome measures in psychotherapy and mental health disorders. He holds a PhD and is an accredited BACP therapist and an accredited IPT practitioner.

More posts

Follow me here –